Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice

European Journal of Immunology

Volumn 31, Issue 7, 2001, Pages 2200-2209

  Perlaza, Blanca Liliana ^a   Sauzet, Jean Pierre ^a   Balde, Aissatou Toure ^b   Brahimi, Karima ^b   Tall, Adama ^a   Corradin, Giampietro ^a,b   Druilhe, Pierre ^a,c  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Epitope mapping; Malaria vaccine; Peptide synthesis

Indexed keywords

ADJUVANT; AMINO ACID; EPITOPE; GAMMA INTERFERON; H2 ANTIGEN; MALARIA VACCINE; PARASITE ANTIGEN; PEPTIDE DERIVATIVE; POLYPEPTIDE; PROTEIN SUBUNIT; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; CHIMPANZEE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDEMIC DISEASE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MALARIA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PEPTIDE SYNTHESIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DOMAIN; SPOROZOITE; T LYMPHOCYTE; VACCINATION;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; B-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; MICE; MICE, INBRED BALB C; PEPTIDES; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0034945823     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200107)31:7<2200::AID-IMMU2200>3.0.CO;2-L     Document Type: Article

References (33)

1. Malaria vaccines
2. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T Lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
3. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides
4. Multiepitopic B- and T cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine
5. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
6. Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein
7. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors
8. Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: Recognition by human T cells and immunogenicity in owl monkeys
9. + T lymphocyte immune responses. Implications for vaccination strategies
10. The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response
11. Immunity to liver stages
12. Pre-erythrocytic malaria vaccine: Mechanisms of protective immunity and human vaccine trials
13. How to select P. falciparum pre-erythrocytic antigens in an expression library without defined probe
14. Protection against Plasmodium falciparum malaria in chimpanzees by immunisation with a conserved pre-erythrocytic antigen, LSA-3
15. DNA immunisation by P. falciparum LSA-3 induces protection against a P. yoelii sporozoite challenge
16. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria
17. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine
18. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules
19. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide
20. Synthesis and immunological characterization of a 134-mer synthetic peptide corresponding to the N-terminal half of the HIV-1 nucleoprotein, p24
21. Solid-phase peptide synthesis and biological activity of bovine thymopoietin II (bTP-II)
22. A simple and rapid procedure for the purification of synthetic polypeptides by a combination of affinity chromatography and methionine chemistry
23. Chemical synthesis of the precursor molecule of the Aequorea green fluorescent protein, subsequent folding, and development of fluorescence
24. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum
25. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: A longitudinal study of 132 children
26. Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans
27. Extracellular processing and presentation of a 69-mer synthetic polypeptide to MHC class I-restricted T cells
28. Capture and processing of exogenous antigens for presentation on MHC molecules
29. + memory T cells
30. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides
31. The Dielmo project: A longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal
32. Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection
33. Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA